US2002038152A1PendingUtilityA1

Compositions and methods for production and use of an injectable naturally secreted extracellular matrix

Assignee: ADVANCED TISSUE SCIENCES INCPriority: Jun 6, 1995Filed: Sep 7, 2001Published: Mar 28, 2002
Est. expiryJun 6, 2015(expired)· nominal 20-yr term from priority
A61Q 19/08A61L 27/3804A61L 27/3633A61F 2/0059A61L 27/3683A61L 27/3839A61F 2/105Y10T442/2525A61L 27/60
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention discloses compositions containing natural human extracellular matrices and methods for the use thereof. More particularly, the present invention provides compositions and methods for the repair of skin defects using natural human extracellular matrix by injection.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method for the production of a naturally secreted extracellular matrix coated three-dimensional framework comprising: 
 (a) culturing cells on a three-dimensional framework under conditions favorable for cellular growth for a pre-determined time period such that an extracellular matrix is secreted onto the inoculated framework creating a coated framework;    (b) killing the cells and    (c) removing the cells and cellular debris.    
     
     
         2 . The method according to  claim 1  wherein the three-dimensional framework is made from a material, said material being selected from the group consisting of polyamide, polyester, polystyrene, polypropylene, polyacrylates, polyvinyl compounds, polycarbonate, polytetrafluorethylene, thermanox, nitrocellulose, cotton, polyglycolic acid, catgut suture material, cellulose, gelatin, chitosan, hyaluronic acid and dextran.  
     
     
         3 . The method according to  claim 1  wherein the three-dimensional framework has pore spaces of about 150 μm to about 220 μm.  
     
     
         4 . The method according to  claim 1  wherein the extracellular matrix is secreted by tissue specific cells.  
     
     
         5 . The method according to  claim 1  wherein the extracellular matrix is secreted by cells, said cells being selected from the group consisting of fibroblasts, osteoblasts, odontoblasts, chondrocytes, epithelial cells, smooth muscle cells, retinal cells, endothelial cells, stromal cells or combinations thereof.  
     
     
         6 . A method for the production of a naturally secreted extracellular matrix comprising: 
 (a) culturing cells on a three-dimensional framework under conditions favorable for cellular growth for a pre-determined time period such that an extracellular matrix is secreted onto the inoculated framework creating a coated framework;    (b) killing the cells;    (c) removing the cells and cellular debris and    (d) collecting the extracellular matrix deposited on the coated framework.    
     
     
         7 . The method according to  claim 6  wherein the three-dimensional framework is made from a material, said material being selected from the group consisting of polyamide, polyester, polystyrene, polypropylene, polyacrylates, polyvinyl compounds, polycarbonate, polytetrafluorethylene, thermanox, nitrocellulose, cotton, polyglycolic acid, catgut sutures, cellulose, gelatin, chitosan, hyaluronic acid and dextran.  
     
     
         8 . The method according to  claim 6  wherein the three-dimensional framework has pore spaces of about 150 μm to about 220 μm.  
     
     
         9 . The method according to  claim 6  wherein the naturally secreted extracellular matrix is secreted by tissue specific cells.  
     
     
         10 . The method according to  claim 6  wherein the naturally secreted extracellular matrix is secreted by cells, said cells being selected from the group consisting of fibroblasts, osteoblasts, odontoblasts, chondrocytes, epithelial cells, smooth muscle cells, retinal cells, endothelial cells, stromal cells or combinations thereof.  
     
     
         11 . A composition comprising a three-dimensional framework, said framework coated with a naturally secreted extracellular matrix composed of human proteins.  
     
     
         12 . The composition according to  claim 11  wherein the framework is made from a material, said material being selected from the group consisting of polyamide, polyester, polystyrene, polypropylene, polyacrylates, polyvinyl compounds, polycarbonate, polytetrafluorethylene, thermanox, nitrocellulose, cotton, polyglycolic acid, catgut sutures, cellulose, gelatin, chitosan, hyaluronic acid and dextran.  
     
     
         13 . The composition according to  claim 11  wherein the three-dimensional framework has pore spaces of about 150 μm to about 220 μm.  
     
     
         14 . The composition according to  claim 11  wherein the naturally secreted extracellular matrix is secreted by tissue specific cells.  
     
     
         15 . The composition according to  claim 11  wherein the naturally secreted extracellular matrix is secreted by cells, said cells being selected from the group consisting of fibroblasts, osteoblasts, odontoblasts, chondrocytes, epithelial cells, smooth muscle cells, retinal cells, endothelial cells, stromal cells or combinations thereof.  
     
     
         16 . An injectable naturally secreted extracellular matrix composition for the treatment of tissue defects comprising a human naturally secreted extracellular matrix and a pharmaceutically acceptable carrier.  
     
     
         17 . The composition according to  claim 16  wherein the naturally secreted extracellular matrix is produced by: 
 (a) culturing cells on a three-dimensional framework under conditions favorable for cellular growth for a pre-determined time period such that an extracellular matrix is secreted onto the inoculated framework creating a coated framework;  
 (b) killing the cells;  
 (c) removing the cells and cellular debris;  
 (d) collecting the naturally secreted extracellular matrix deposited on the coated framework and  
 (e) processing the collected extracellular matrix with a pharmaceutically acceptable carrier.  
 
     
     
         18 . The composition according to  claim 17  wherein naturally secreted extracellular matrices secreted by different tissue or cell types are mixed between steps (d) and (e), such that ratios of collagen types I-V, respective to each other, are adjusted.  
     
     
         19 . The composition according to  claim 16  wherein the framework is made from a material, said material being selected from the group consisting of polyamide, polyester, polystyrene, polypropylene, polyacrylates, polyvinyl compounds, polycarbonate, polytetrafluorethylene, thermanox, nitrocellulose, cotton, polyglycolic acid, catgut sutures, cellulose, gelatin, chitosan, hyaluronic acid and dextran.  
     
     
         20 . The composition according to  claim 16  wherein the three-dimensional framework has pore spaces of about 150 μm to about 220 μm.  
     
     
         21 . The composition according to  claim 16  wherein the naturally secreted extracellular matrix is secreted by tissue specific cells.  
     
     
         22 . The composition according to  claim 16  wherein the naturally secreted extracellular matrix is secreted by cells, said cells being selected from the group consisting of fibroblasts, osteoblasts, odontoblasts, chondrocytes, epithelial cells, smooth muscle cells, retinal cells, endothelial cells, stromal cells or combinations thereof.  
     
     
         23 . A method for the repair of tissue defects comprising injecting a naturally secreted extracellular matrix in a pharmaceutically acceptable carrier at the site of the tissue defect.  
     
     
         24 . The method according to  claim 23  wherein the naturally secreted extracellular matrix is produced by: 
 (a) culturing cells on a three-dimensional framework under conditions favorable for cellular growth for a pre-determined time period such that an extracellular matrix is secreted onto the inoculated framework creating a coated framework;  
 (b) killing the cells;  
 (c) removing the cells and cellular debris;  
 (d) collecting the naturally secreted extracellular matrix deposited on the coated framework and  
 (e) processing the collected extracellular matrix with a pharmaceutically acceptable carrier.  
 
     
     
         25 . The method according to  claim 23  wherein naturally secreted extracellular matrices secreted by different tissue or cell types are mixed between steps (d) and (e), such that ratios of collagen types I-V, respective to each other, are adjusted.  
     
     
         26 . The method according to  claim 23  wherein the framework is made from a material, said material being selected from the group consisting of polyamide, polyester, polystyrene, polypropylene, polyacrylates, polyvinyl compounds, polycarbonate, polytetrafluorethylene, thermanox, nitrocellulose, cotton, polyglycolic acid, catgut sutures, cellulose, gelatin, chitosan, hyaluronic acid and dextran.  
     
     
         27 . The method according to  claim 23  wherein the three-dimensional framework has pore spaces of about 150 μm to about 220 μm.  
     
     
         28 . The method according to  claim 23  wherein the naturally secreted extracellular matrix is secreted by tissue specific cells.  
     
     
         29 . The method according to  claim 23  wherein the naturally secreted extracellular matrix is secreted by cells, said cells being selected from the group consisting of fibroblasts, osteoblasts, odontoblasts, chondrocytes, epithelial cells, smooth muscle cells, retinal cells, endothelial cells, stromal cells or combinations thereof.

Join the waitlist — get patent alerts

Track US2002038152A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.